MapLight Therapeutics plans 36,979-share stock sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. has a notice covering the proposed sale of 36979 shares of MapLight voting common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 1401874.00 and an approximate sale date of 07/15/2026. The shares are associated with a restricted stock unit settlement. The notice also lists prior April 2026 sales of MapLight voting common stock, including transactions for 3590, 51900 and 17935 shares on 04/15/2026, 04/27/2026 and 04/28/2026, respectively, with corresponding cash proceeds disclosed.
Key Figures
Key Terms
Securities To Be Sold regulatory
Restricted stock unit settlement financial
Securities Sold During The Past 3 Months regulatory
voting common stock market
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is covered in MapLight Therapeutics (MPLT) Form 144?
What prior MapLight Therapeutics (MPLT) stock sales are disclosed for the past 3 months?
AI-generated analysis. How Rhea-AI works. Not financial advice.